ArticleHuman immunology2022

Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2.

Rupal Ojha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.